活性氧通过TXNIP-NLRP3-NR2B通路参与2型糖尿病神经病理性疼痛
本研究在2型糖尿病神经病理性疼痛(DNP)大鼠模型及高糖细胞模型中,探讨ROS-TXNIP-NLRP3-NR2B通路的作用。结果显示DNP大鼠脊髓ROS升高,ROS清除剂PBN或TXNIP敲低可减轻痛觉过敏并降低NLRP3、caspase-1、IL-1β及p-NR2B水平,提示该通路参与DNP机制。
要点
- 脊髓ROS升高通过TXNIP-NLRP3-NR2B通路促进2型DNP。
- ROS清除剂PBN或TXNIP敲低可减轻DNP大鼠痛觉过敏。
- 高糖环境下BV2与PC12共培养中该通路激活可被PBN阻断。
核心结论
- 脊髓ROS通过TXNIP-NLRP3-NR2B通路参与2型糖尿病神经病理性疼痛。
研究设计与样本
- 雄性Sprague-Dawley大鼠高脂高糖饮食8周后腹腔注射链脲佐菌素(STZ,35 mg/kg)诱导2型糖尿病,将机械缩足阈值和热缩足潜伏期低于基础水平85%者判定为DNP大鼠。
- DNP大鼠每日给予ROS清除剂PBN(100 mg·kg⁻¹·d⁻¹)或TXNIP小干扰RNA(10 μg/d)治疗14天。
- 体外实验将BV2细胞与PC12细胞分别培养及在高糖环境(35 mmol/L D-葡萄糖)下共培养。
主要发现
- DNP大鼠脊髓ROS水平升高,全身给予PBN可减轻机械性痛觉过敏和热痛觉过敏。
- PBN降低DNP大鼠脊髓NLRP3、TXNIP、caspase-1、IL-1β和p-NR2B蛋白水平及TXNIP与NLRP3的偶联。
- 脊髓TXNIP敲低减轻DNP大鼠痛觉过敏,并降低NLRP3、TXNIP、caspase-1、IL-1β和p-NR2B蛋白水平。
- 高糖环境下BV2细胞ROS水平及NLRP3、TXNIP、caspase-1、IL-1β蛋白水平、TXNIP与NLRP3偶联和IL-1β分泌增加,共培养PC12细胞p-NR2B表达增加,PBN可阻断上述体外效应。
临床怎么用
- 提示靶向脊髓ROS-TXNIP-NLRP3-NR2B通路可能为2型糖尿病神经病理性疼痛提供潜在治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The number of patients with diabetic neuropathic pain (DNP) continues to increase, but available treatments are limited. This study aimed to examine the influence of reactive oxygen species (ROS)-thioredoxin-interacting protein (TXNIP)-NOD-like receptor protein 3 (NLRP3)- N -methyl-D-aspartic acid receptor 2B (NR2B) pathway on type 2 DNP. METHODS: Male Sprague-Dawley rats were fed with a high-fat and high-sugar diet for 8 weeks. Then, rats were intraperitoneally injected with streptozotocin (STZ, 35 mg/kg) to induce type 2 diabetes mellitus in rats. Diabetic rats with <85% of their basic levels in mechanical withdrawal threshold and thermal withdrawal latency were classified as DNP rats on day 14 after STZ injection. DNP rats were treated with ROS scavenger N-tert-Butyl-α-phenylnitrone (PBN, 100 mg·kg -1 ·d -1 ) or TXNIP small interfering ribonucleic acid (10 μg/d) once daily for 14 days. The level of ROS, protein levels of NLRP3, TXNIP, cysteinyl aspartate-specific proteinase-1 (caspase-1), interleukin-1β (IL-1β), NR2B phosphorylation at Tyr1472 (p-NR2B), total NR2B (t-NR2B), and distribution of NLRP3 in the spinal cord were examined. In vitro experiments, BV2 cells and PC12 cells were individually cultured and cocultured in a high-glucose environment (35 mmol/L D-glucose). The level of ROS and protein levels of NLRP3, TXNIP, caspase-1, and IL-1β in BV2 cells, and p-NR2B, t-NR2B in PC12 cells were detected. The level of ROS was detected by the flow cytometry approach. The protein levels were detected by the Western blot technique. The location of NLRP3 was observed by immunofluorescent staining. The interaction between TXNIP and NLRP3 was detected by coimmunoprecipitation assay. RESULTS: The level of spinal ROS increased in DNP rats. The mechanical allodynia and thermal hyperalgesia of DNP rats were alleviated after systemic administration of PBN. This administration decreased protein levels of NLRP3, TXNIP, caspase-1, IL-1β, and p-NR2B and the coupling of TXNIP to NLRP3 in spinal cords of DNP rats. Furthermore, knockdown of spinal TXNIP alleviated nociceptive hypersensitivity and decreased protein levels of NLRP3, TXNIP, caspase-1, IL-1β, and p-NR2B in DNP rats. The level of ROS and protein levels of NLRP3, TXNIP, caspase-1, IL-1β, the coupling of TXNIP to NLRP3, and the IL-1β secretion increased in BV2 cells, and the protein expression of p-NR2B increased in cocultured PC12 cells in a high-glucose environment. All of these in vitro effects were significantly blocked after treatment of PBN. CONCLUSIONS: Our findings suggest that spinal ROS can contribute to type 2 DNP through TXNIP-NLRP3-NR2B pathway.
引用
- Wang JW, Ye XY, Wei N, et al. Reactive Oxygen Species Contributes to Type 2 Diabetic Neuropathic Pain via the Thioredoxin-Interacting Protein-NOD-Like Receptor Protein 3- N -Methyl-D-Aspartic Acid Receptor 2B Pathway. Anesth Analg. 2022. PMID: 35819160. doi:10.1213/ANE.0000000000006117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。